Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Dicerna provides interim data from phase I study of belcesiran in AATLD

July 22, 2021

Rheos Medicines discloses MALT1 inhibitors

July 22, 2021

Medshine Discovery patents new KHK inhibitors for NASH

July 22, 2021

Medshine Discovery patents new compounds for NASH

July 21, 2021

Prometheus initiates phase II ARTEMIS-UC study of PRA-023

July 20, 2021

Hepion reports phase IIa topline data on CRV-431 in presumed F2 and F3 NASH

July 14, 2021

New furaneol glycoside compounds divulged by Fudan University

July 13, 2021

Discovery, optimization and in vivo evaluation of novel tetrahydropyran-based galectin-3 inhibitors

July 9, 2021

Scientists describe new model of primary sclerosing cholangitis-associated cholangiocarcinoma

July 8, 2021

New TGF-beta inhibitor KS-356 improves experimental obesity, hepatic steatosis

July 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...